News
Akayed Ullah Convicted for Detonation of a Bomb in New York City
- Details
- Written by Justice Department Justice Department
- Published: 10 November 2018 10 November 2018
New York - Akayed Ullah, 28, of Brooklyn, New York, and a lawful permanent resident from Bangladesh, was convicted today on all six counts of the Indictment, which charged him with offenses related to the detonation and attempted detonation of a bomb in a subway station near the New York Port Authority Bus Terminal in New York City on Dec. 11, 2017.
Patient Recruiter Convicted in $1.1 Million Kickback Scheme
- Details
- Written by DOJ DOJ
- Published: 10 November 2018 10 November 2018
Detroit, Michigan - On Friday, November 2, a federal jury found a patient recruiter guilty for her role in a scheme involving approximately $1.1 million in fraudulent Medicare claims for home health care that were procured through the payment of kickbacks.
Presidential Proclamation on National Apprenticeship Week, 2018
- Details
- Written by White House White House
- Published: 10 November 2018 10 November 2018
Washington, DC - Under my Administration’s policies, our Nation’s economy is booming and Americans have more opportunities than ever before. Men and women from all walks of life are moving off the sidelines and into the workforce. In this economic context, our country needs workers with world-class skills and abilities to fill vacant positions in the labor force.
President Trump and President Macron of France Before Bilateral Meeting
- Details
- Written by White House White House
- Published: 10 November 2018 10 November 2018
Washington, DC - Remarks by President Trump and President Macron of France Before Bilateral Meeting:
New efforts to strengthen FDA’s expanded access program
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D. FDA Commissioner Scott Gottlieb, M.D.
- Published: 09 November 2018 09 November 2018
Washington, DC - Since the 1970s, the FDA has helped to facilitate access to promising investigational medical products for patients with serious or immediately life-threatening diseases who are unable to access products through clinical trials. As a cancer survivor, I understand, on a very personal level, that patients who are fighting serious or life-threatening diseases want the flexibility to try new therapeutic approaches, including investigational medical products. This is especially relevant when there’s no other FDA-approved treatment option available to a patient.